Stock Code

300122

English
English 中文
Contact Us
About
Development History Social Honor
R&D and Innovation
R&D Strength R&D Pipeline
Products & Services
Self-Developed Products International Development
Investor Relations
Company Announcement
Contact
Contact Information
R&D and Innovation
R&D Strength R&D Pipeline
Home/R&D and Innovation /R&D Strength
R&D and Production Footprint (map)
0
R&D Headcount
0
R&D Investment (billion / CNY)
*2025
Shanghai
R&D Center
Anhui
R&D Center
Industrialization Base
Beijing
R&D Center
Industrialization Base
Innovation Incubator
Chongqing
R&D Center
Industrialization Base
Technology platforms
AI-Driven Drug-Discovery Platforms
AI-Driven Drug-Discovery Platforms
Gene Editing
Gene Editing
Synthetic Biology
Synthetic Biology
Structural Vaccinology
Structural Vaccinology
Human Diploid Cell Culture
Human Diploid Cell Culture
Outer-Membrane Vesicle (OMV) Delivery
Outer-Membrane Vesicle (OMV) Delivery
Next-Generation Vaccine Adjuvants
Next-Generation Vaccine Adjuvants
Nanoparticle Self-Assembly
Nanoparticle Self-Assembly
Novel Intranasal Delivery
Novel Intranasal Delivery
Multivalent
Multivalent
Polysaccharide-Protein Conjugate
Polysaccharide-Protein
Conjugate
Recombinant Protein
Recombinant Protein
Inactivated & Attenuated
Inactivated & Attenuated
Long-Acting Peptide Therapeutics
Long-Acting Peptides
mRNA
mRNA
Viral-Vector Delivery
Viral-Vector
Delivery
Product matrix
Respiratory Vaccines
Respiratory Vaccines
Respiratory Vaccines
Enteric (Gastrointestinal) Vaccines
Enteric (Gastrointestinal) Vaccines
Enteric (Gastrointestinal) Vaccines
Tuberculosis Products
Tuberculosis Products
Tuberculosis Products
Oncology-Related Vaccines
Oncology-Related Vaccines
Oncology-Related Vaccines
Multi-Combo Vaccines
Multi-Combo Vaccines
Multi-Combo Vaccines
Adult Vaccines
Adult Vaccines
Adult Vaccines
Metabolic-Disease Therapeutics
Metabolic-Disease Therapeutics
Metabolic-Disease Therapeutics